Gilead Agrees to Pay $97 Million to Resolve Alleged False Claims Act Liability for Paying Kickbacks

California-based pharmaceutical company Gilead Sciences has agreed to pay $97 million to resolve claims that it violated the False Claims Act by illegally using a charitable foundation as a conduit to pay the copays of thousands of Medicare patients taking Gilead’s pulmonary arterial hypertension drug, Letairis. From 2007 through 2010, Gilead allegedly obtained information from […]
Must be a Paid Member or a Free Trial Member to Access Content. Members log in here.